Drawing for DUOBODY

USPTO serial 79093886

DUOBODY

Reviewed by CopyMark Law Group

Reg. 4103714Status 706Registered
Filing date
Status date
Registration date
Feb 28, 2012
Examiner
SMIGA, HOWARD
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with DUOBODY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 Lexington AvenueNew York, NY 10174United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseasesACTIVE—
005Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseasesACTIVE—
042Medical and scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodiesACTIVE—
045Patent exploitation, namely, patent licensing ; licensing of intellectual property in the field of medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 5, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 5, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 15, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 7, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 7, 202371AGREGISTERED-SEC.71 ACCEPTED—
Feb 6, 2023EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 4, 2022PR71POST REGISTRATION ACTION MAILED - SEC.71—
Aug 2, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 28, 2022ES71TEAS SECTION 71 RECEIVED—
Feb 28, 2021REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jan 21, 2021RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 7, 2018NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 7, 201871AGREGISTERED-SEC.71 ACCEPTED—
Sep 7, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 27, 2018ES71TEAS SECTION 71 RECEIVED—
Oct 26, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 8, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 20, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 4, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 15, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 15, 2012FIMPFINAL DISPOSITION PROCESSED—
May 28, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 28, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2011NPUBNOTICE OF PUBLICATION—
Nov 10, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 7, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 7, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2011ALIEASSIGNED TO LIE—
Oct 13, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2011PETGPETITION TO REVIVE-GRANTED—
Oct 13, 2011PROATEAS PETITION TO REVIVE RECEIVED—
Jun 3, 2011NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 17, 2011RFNTREFUSAL PROCESSED BY IB—
Mar 29, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 29, 2011RFRRREFUSAL PROCESSED BY MPU—
Mar 29, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 28, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2011DOCKASSIGNED TO EXAMINER—
Mar 22, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance